6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex

Journal of Neuroscience Research

Volumn 86, Issue 7, 2008, Pages 1647-1658

  Devoto, Paola ^a,d   Flore, Giovanna ^a   Saba, Pierluigi ^a   Castelli, M Paola ^a   Piras, A Paola ^a   Luesu, William ^a   Viaggi, M Cristina ^b   Ennas, M Grazia ^a   Gessa, Gian Luigi ^a,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c CNR   (Italy)

^d BB Brodie Department of Neuroscience   (Italy)

Author keywords

DAT; Haloperidol; Immunohistochemistry; Microdialysis; Noradrenaline; RS 79948

Indexed keywords

12 ETHYLSULFONYL 5,8,8A,9,10,11,12,12A,13,13A DECAHYDRO 3 METHOXY 6H ISOQUINO[2,1 G][1,6]NAPHTHYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; CATECHOLAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; NORADRENALIN; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; BRAIN DAMAGE; CONTROLLED STUDY; DENERVATION; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EXTRACELLULAR MATRIX; HEMISPHERE; IMMUNOREACTIVITY; INNERVATION; MALE; MICRODIALYSIS; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG INTERACTIONS; EXTRACELLULAR FLUID; HALOPERIDOL; ISOQUINOLINES; MALE; MICRODIALYSIS; NAPHTHYRIDINES; NOREPINEPHRINE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHOLYTICS; VENTRAL TEGMENTAL AREA;

EID: 43149103407     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21611     Document Type: Article

References (38)

1. Abercrombie ED, Zigmond MJ. 1989. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci 9:4062-4067.
2. Acheson AL, Zigmond MJ. 1981. Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons. J Neurosci 1:493-504.
3. Audet MA, Doucet G, Oleskevich , Descarries L. 1988. Quantified regional and laminar distribution of the noradrenaline innervation in the anterior half of the adult rat cerebral cortex. J Comp Neurol 273:224-240.
4. Carboni E, Tanda GL, Frau R, Di Chiara G. 1990. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
5. Castaneda E, Whishaw IQ, Robinson TE. 1990. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10:1847-1854.
6. Chiodo LA, Acheson AL, Zigmond MJ, Strieker EM. 1983. Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells. Brain Res 264:123-126.
7. Ciliax BJ, Hellman C, Demchyshyn LL, Pritupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI. 1995. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
8. Descarries L, Lemay B, Doucet G, Berger B. 1987. Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21:807-824.
9. Devoto P, Flore G. 2006. On the origin of cortical dopamine: is it a cotransmitter in noradrenergic neurons? Curr Neuropharmacol 4:115-125.
10. Devoto P, Flore G, Pani L, Gessa GL. 2001. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657-664.
11. Devoto P, Flore G, Vacca G, Pira L, Area A, Casu MA, Pani L, Gessa GL. 2003a. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology 167:79-84.
12. Devoto P, Flore G, Longu G, Pira L, Gessa GL. 2003b. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse 50:200-205.
13. 2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J Neurochem 88:1003-1009.
14. Devoto P, Flore G, Pira L, Longu G, Gessa GL. 2004b. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487:105-111.
15. Devoto P, Flore G, Saba P, Fà M, Gessa GL. 2005a. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus. BMC Neuroscience 6:31 [http://www.biomedcentral.com/1471-2202/6/31].
16. Devoto P, Flore G, Saba P, Fà M, Gessa GL. 2005b. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem 92:368-374.
17. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR, Kuhar MJ. 1995. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359:340-349.
18. Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. 2000. Dissociation of haloperidol, clozapine and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology 22:642-649.
19. Heidbreder CA, Foxton R, Cilia J, Hughes ZA, Shah AJ, Atkins A, Hunter AJ, Hagan JJ, Jones DNC. 2001. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology 156:338-351.
20. Hertel P, Nomikos GG, Svensson TH. 1999. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur J Pharmacol 371:153-158.
21. Hollerman JR, Grace AA. 1990. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res 533:203-212.
22. 2-adrenoceptors. Eur J Pharmacol 317:67-73.
23. Kawahara H, Kawahara Y, Westerink BHC. 2001. The noradrenaline-dopamine interactions in the rat medial prefrontal cortex studied by multiprobe microdialysis. Eur J Pharmacol 418:177-186.
24. Kuroki T, Meltzer HY, Ichikawa J. 1999. Effect of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288:774-781.
25. Li X-M, Perry KW, Wong DT, Bymaster FP. 1998. Olanzapine increases in vivo dopamine and noradrenaline release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153-161.
26. Lindvall O, Björklund A, Divac I. 1978. Organization of the catecholamine neurons projecting to the frontal cortex in the rat. Brain Res 142:1-24.
27. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT. 2002. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389-395.
28. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates,3rd ed. San Diego: Academic Press.
29. Pehek EA, Yamamoto BK. 1994. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63:118-2124.
30. Robinson TE, Mocsary Z, Camp DM, Whishaw IQ. 1994. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 14:2687-2696.
31. Sarre S, Yuan H, Jonkers N, Van Hemelrijck A, Ebinger G, Michotte Y. 2004. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats. J Neurochem 90:29-39.
32. Scatton B, Dennis T, Curet O. 1984. Increase in dopamine and DOPAC levels in noradrenergic terminals after electrical stimulation of the ascending noradrenergic pathways. Brain Res 298:193-196.
33. Schwarting RKW, Huston JP. 1996. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49:215-266.
34. Tassin JP, Lavielle S, Herve D, Blanc G, Thierry AM, Alvarez C, Berger B, Glowinski J. 1979. Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles. Neuroscience 4:1569-1582.
35. 2C- adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. Eur J Pharmacol 343:93-101.
36. Valentini V, Frau R, Di Chiara G. 2004. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J Neurochem 88:917-927.
37. Valentini V, Cacciapaglia F, Frau R, Di Chiara G. 2005. Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation. J Neurochem 93:371-382.
38. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. 1990. Compensation after lesion of central dopaminergic neurons: some clinical and basic implications. TINS 13:290-296.